7th Mar 2016 15:21
RNS Number : 3025R
Circassia Pharmaceuticals Plc
07 March 2016
7 March 2016
Circassia Pharmaceuticals PLC
Notice of Preliminary Results
Circassia Pharmaceuticals plc (LSE: CIR), a specialty biopharmaceutical company focused on allergy and respiratory medicine, will announce its preliminary results for the year ended 31 December 2015 on Friday 11 March 2016.
A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.
For further information please contact:
FTI Consulting | |
Mo Noonan / Matt Moss | +44 (0) 20 3727 1000 |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
CIR.L